Interpace Diagnostics Revenue and Competitors

Parsippany, NJ USA

Location

$9.4M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Interpace Diagnostics's estimated annual revenue is currently $28.3M per year.(i)
  • Interpace Diagnostics's estimated revenue per employee is $193,750
  • Interpace Diagnostics's total funding is $9.4M.

Employee Data

  • Interpace Diagnostics has 146 Employees.(i)
  • Interpace Diagnostics grew their employee count by -2% last year.

Interpace Diagnostics's People

NameTitleEmail/Phone
1
President and CEOReveal Email/Phone
2
President & CEOReveal Email/Phone
3
SVP MarketingReveal Email/Phone
4
VP Sales Endocrine DivisionReveal Email/Phone
5
VP, Assay DevelopmentReveal Email/Phone
6
VP PathologyReveal Email/Phone
7
SVP OperationsReveal Email/Phone
8
VP Clinical DevelopmentReveal Email/Phone
9
VP GI SalesReveal Email/Phone
10
Senior Director Laboratory OperationsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$8.7M562%N/AN/A
#2
$0.2M10%N/AN/A
#3
$5.7M37-33%N/AN/A
#4
$114.8M5296%N/AN/A
#5
$0.8M50%N/AN/A
#6
$0.6M40%N/AN/A
#7
$14.7M83-22%$206.4MN/A
#8
$492.2M1834-15%$568MN/A
#9
$1.9M1271%N/AN/A
#10
$4.8M317%N/AN/A
Add Company

What Is Interpace Diagnostics?

Interpace DiagnosticsInterpace Diagnostics develops molecular diagnostic tests. Our molecular diagnostic tests provide unparalleled accuracy and clarity to improve outcomes in patients facing a cancer diagnosis. You can be assured that all of the molecular tests we offer are driven by rigorous, validated science.

keywords:N/A

$9.4M

Total Funding

146

Number of Employees

$28.3M

Revenue (est)

-2%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Interpace Diagnostics News

2022-03-22 - Interpace Biosciences Announces Full Year and Fourth ...

Clinical services, through Interpace Diagnostics, provides clinically useful molecular diagnostic tests, bioinformatics and pathology...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$24.6M1542%N/A
#2
$53.3M15921%N/A
#3
$47.5M1603%N/A
#4
$47.5M16030%N/A
#5
$25.7M1617%N/A